Get Free Delivery With No Minimum Order

DULCOLAX 5/MG TAB 40/TAB
- Sku : I-029781
Key features
DULCOLAX 5 mg coated tablets contain the active ingredient bisacodyl 5 mg. As a stimulant laxative, bisacodyl is converted in the colon to an active metabolite that stimulates enteric nerves to increase colonic peristalsis and promotes fluid and electrolyte secretion into the bowel, facilitating stool passage. It is indicated for short-term relief of occasional constipation and for bowel evacuation or cleansing as part of preparation for diagnostic procedures or surgery. Available OTC in packs of 40 coated tablets.- Brand: DULCOLAX
- Active Ingredient: BISACODYL 5mg
- Strength: 5mg
- Dosage Form: Coated tablet
- Pack Size: 40 Tablets
- Route: Oral use
- Prescription Status: OTC
- Therapeutic Class: Gastrointestinal
- Pharmacological Group: Laxatives
- Drug Class: Stimulant Laxative (Diphenylmethane derivative)
- Manufacturer: DELPHARM REIMS S.A.S
- Country of Origin: France
- SFDA Registration No.: 2807245667
- Shelf Life: 36 months
- Storage: store below 30°c
- Gi Condition: Constipation
Indications
Approved Uses
Short‑term relief of occasional constipation; bowel evacuation/cleansing as part of preparation for diagnostic procedures or surgery when directed.
Dosage & Administration
Dosing by Condition
Adults_and_children_12_years_and_over: 5-10 mg orally once daily, preferably at bedtime.
Children_6_to_under_12_years: 5 mg orally once daily at bedtime (use under medical advice).
Children_under_6_years: Not recommended.
Initial Dose
5-10 mg orally once daily at bedtime.
Maintenance Dose
5-10mg once daily as needed; not intended for long-term daily use
Maximum Dose
Adults and ≥12 years: 5-10 mg orally once daily (maximum 10 mg/day) for constipation; children 6-11 years: 5 mg once daily (maximum 5 mg/day).
Dose Adjustment Notes
No specific renal/hepatic dose adjustment is generally required, but use the lowest effective dose for the shortest duration; do not use longer than 7 days (often 5-7 days) unless directed by a clinician due to risk of electrolyte imbalance and laxative dependence with prolonged use.
How to Take
Swallow the enteric‑coated tablet whole with a full glass of water; do not crush, chew, or split. Take preferably at bedtime for an effect the next morning. Avoid taking within 1 hour of antacids or milk/dairy (and other acid‑reducing agents) to prevent premature dissolution of the enteric coating.
Side Effects
Common Side Effects
Abdominal cramping/pain, diarrhea, nausea; less commonly vomiting.
Side Effect Frequency
Common: abdominal pain/cramps, diarrhea, nausea. Other reported: vomiting, dizziness, syncope, haematochezia, dehydration, hypersensitivity reactions; with prolonged/excess use-electrolyte disturbances (e.g., hypokalemia).
Safety & Warnings
Contraindications
Hypersensitivity to bisacodyl/excipients; intestinal obstruction or ileus; acute surgical abdomen/acute abdominal conditions (e.g., appendicitis) or severe abdominal pain with nausea/vomiting; severe dehydration.
Warnings & Precautions
Do not use longer than ~5-7 days without medical advice; swallow tablets whole (do not crush/chew); avoid taking within 1 hour of antacids, milk/dairy, or acid-suppressing agents; overuse may cause dehydration/electrolyte imbalance and dependence-like use; stop and seek medical advice for rectal bleeding, severe abdominal pain, or no bowel movement after use.
Driving Warning
Caution advised; may cause dizziness/syncope due to vasovagal response (e.g., abdominal spasm); avoid driving if abdominal spasm occurs.
Drug Interactions
Drug Interactions
Avoid taking within 1 hour of antacids, milk/dairy, or acid-suppressing agents (H2 blockers/PPIs) due to premature dissolution of the enteric coating; caution with diuretics or systemic corticosteroids (↑ hypokalemia risk with excessive/prolonged use); hypokalemia may increase digoxin/cardiac glycoside toxicity risk.
Interaction Severity
MODERATE: Antacids, milk/dairy, and other acid‑reducing agents (e.g., H2 blockers, PPIs) may cause premature dissolution of the enteric coating-separate by at least 1 hour. MODERATE: Diuretics and systemic corticosteroids-additive risk of hypokalemia/dehydration with laxative overuse. MODERATE: Cardiac glycosides (e.g., digoxin)-hypokalemia from excessive laxative use can increase toxicity risk.
Food Interaction
Avoid taking within 1 hour of milk/dairy; preferably take with water (often at bedtime) and avoid coadministration with antacids/acid-suppressing agents that can dissolve the enteric coating prematurely.
Special Populations
Pregnancy
Caution
Elderly
Standard adult dosing; use the lowest effective dose and shortest duration due to increased risk of electrolyte disturbances and dehydration
Storage & Patient Advice
Stopping the Medicine
Safe to stop anytime; no tapering required. Not intended for long-term daily use-seek medical advice if constipation persists or if use is needed beyond ~5-7 days.
Overdose
Overdose may cause severe diarrhea, abdominal cramps, dehydration, and electrolyte disturbances (notably hypokalemia); management is supportive with fluid/electrolyte replacement and medical evaluation (no specific antidote).
Patient Counseling
Swallow the 5 mg enteric‑coated tablet whole with water; do not crush/chew/split. Take at bedtime; expect a bowel movement in ~6-12 hours. Do not take within 1 hour of milk/dairy, antacids, or acid‑reducing medicines. Use short term only; avoid continuous use beyond 5-7 days unless advised by a clinician. Maintain hydration; stop and seek medical advice for severe/persistent abdominal pain, rectal bleeding, or no bowel movement after use.
Monitoring Requirements
No routine monitoring for short-term use; monitor electrolytes (potassium, sodium) if used long-term or in at-risk patients
Pharmacology
Mechanism of Action
Stimulant laxative that is converted in the colon to an active metabolite which stimulates colonic enteric nerves to increase peristalsis and promotes fluid/electrolyte secretion into the lumen, facilitating stool passage.
Onset of Action
Oral enteric‑coated tablet: about 6-12 hours.
Duration of Effect
Typically produces a bowel movement in about 6-12 hours after an oral enteric‑coated tablet dose.
Bioavailability
Minimal systemic absorption; oral bioavailability is very low (generally reported as <5%).
Product Information
Available Dosage Forms
Enteric-coated tablet, Rectal suppository, Rectal enema.
Composition per Dose
Each enteric-coated tablet: 5mg bisacodyl
Generic Availability
Yes
Gi Condition
Constipation
Legal Disclaimer - Al Mujtama Pharmacy
The product information provided is derived from verified pharmaceutical references and is intended for general health education only. It is not a substitute for professional medical advice, diagnosis, or treatment.
Al Mujtama Pharmacy assumes no legal or medical liability for:
- Any therapeutic decision made based on the information displayed without consulting a licensed physician or pharmacist
- Any discrepancy between the information provided and the product's package insert or SFDA guidelines
- Any misuse of medication resulting from personal interpretation of the content displayed
Important notice: Drug formulations and instructions may vary between production batches. Always rely on the leaflet included inside the product packaging you have, and consult your pharmacist or physician before starting, adjusting, or discontinuing any medication.
By using this content, you acknowledge that you have read this disclaimer and agree that Al Mujtama Pharmacy bears no liability arising from reliance on this information as a substitute for direct medical consultation.
Your health is a trust - always consult your doctor first.
-1744229570.gif)



